Connection

Sara Monti to Betacoronavirus

Back to Details
This is a "connection" page, showing publications Sara Monti has written about Betacoronavirus.
Sara Monti
Connection Strength
0.056
Betacoronavirus
  1. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020 05; 79(5):667-668.
    View in: PubMed
    Score: 0.037
  2. Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis. Ann Rheum Dis. 2020 12; 79(12):1658-1659.
    View in: PubMed
    Score: 0.009
  3. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Ann Rheum Dis. 2020 06; 79(6):e62.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.